Tuberculosis patients living with HIV receiving antiretroviral therapy in Costa Rica
Costa Rica: Tuberculosis patients living with HIV receiving antiretroviral therapy was 38 patients in 2019. ◆ Volatile
Tuberculosis patients living with HIV receiving antiretroviral therapy in Costa Rica, 2003–2019
Source: Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data. Measured in patients.
Analysis
In 2019, tuberculosis patients living with hiv receiving antiretroviral therapy in Costa Rica stood at 38 patients.
That represents a change of down 7.3% on the previous year and down 7.3% over five years.
Over the whole period, tuberculosis patients living with hiv receiving antiretroviral therapy in Costa Rica peaked at 54 patients in 2012 and was at its lowest, 0 patients, in 2010.
That places Costa Rica 91st out of 183 countries with data for 2019, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Tuberculosis patients living with HIV receiving antiretroviral therapy in Costa Rica, year by year
| Year | patients | Change |
|---|---|---|
| 2003 | 15 patients | — |
| 2005 | 42 patients | +180.0% |
| 2010 | 0 patients | -100.0% |
| 2011 | 0 patients | — |
| 2012 | 54 patients | — |
| 2013 | 36 patients | -33.3% |
| 2014 | 41 patients | +13.9% |
| 2015 | 31 patients | -24.4% |
| 2016 | 31 patients | +0.0% |
| 2017 | 23 patients | -25.8% |
| 2018 | 41 patients | +78.3% |
| 2019 | 38 patients | -7.3% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 28.5 patients | 15 patients | 42 patients | 2 |
| 2010s | 29.5 patients | 0 patients | 54 patients | 10 |
Countries ranked near Costa Rica
More health data for Costa Rica
- Un projection of annual infant deaths, annual growth rate -2.78 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.4617 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,632 deaths per 1,000 people (2090)
- Number of infants who die before age 1 35 deaths (2100)
- Population ages 15-19, male, annual growth rate -0.1629 % change on previous year (2025)
- Population ages 15-19, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 15-19, male, per capita 0.0358 units per person (2025)
- Population ages 20-24, female, annual growth rate -1.91 % change on previous year (2025)
- Population ages 20-24, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 20-24, female, per capita 0.0352 units per person (2025)
Frequently asked questions
- What is tuberculosis patients living with hiv receiving antiretroviral therapy in Costa Rica?
- Tuberculosis patients living with hiv receiving antiretroviral therapy in Costa Rica was 38 patients in 2019, according to Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data.
- What is the highest tuberculosis patients living with hiv receiving antiretroviral therapy recorded in Costa Rica?
- The highest recorded value was 54 patients in 2012.
- What is the lowest tuberculosis patients living with hiv receiving antiretroviral therapy recorded in Costa Rica?
- The lowest recorded value was 0 patients in 2010.
- How does Costa Rica rank for tuberculosis patients living with hiv receiving antiretroviral therapy?
- Costa Rica ranks 91st out of 183 countries with data for 2019.
- Where does this Costa Rica data come from?
- The figures come from Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data, published as part of Tuberculosis patients living with HIV receiving antiretroviral therapy. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 12 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Number of tuberculosis patients who are living with HIV and receiving antiretroviral therapy.